Short answer
NOVANTA INC (NOVT) filed an 8-K current report with the SEC on August 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Fiscal quarter ended July 3, 2026 results announced.
NOVANTA INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal quarter ended July 3, 2026 results announced
- Exhibit 99.1 contains Novanta’s detailed financial results and management commentary
- Furnished under Item 2.02, signaling earnings disclosure rather than a new filing obligation
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue rose 10.3% to $265.8M, with organic growth of 9.3%, indicating broad-based underlying demand
- Adjusted EBITDA increased 16.4% to $60.7M, expanding margin to 22.8% from 21.6%
- GAAP net income reached $12.5M versus $4.5M, while adjusted diluted EPS rose 17.1% to $0.89
- Operating cash flow surged to $64.9M from $15.1M, supporting $57.5M of free cash flow
- 2026 guidance raised to $1,130M–$1,140M revenue and $3.68–$3.74 adjusted EPS, incorporating Riverpoint Medical acquisition benefits
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other NOVANTA INC 8-K filings
Get the next NOVT 8-K as it lands
Follow NOVT for push alerts, or ask the research agent what this filing means.